Biotech Values

[DewDiligence]

New survey on investing in the biogeneric arena:

Q: Which of the following companies is the
best way to play the emergence of biogeneric
and biosimilar drugs during the next 5 years?

a) BRL
b) EMIS
c) GTCB
d) MAXY
e) MNTA
f) MYL
g) NSTK
h) NTEC
i) NVS (Sandoz)
j) PLX
k) SBS.to
l) TEVA
m) A company not listed above

To vote, please go to
http://www.investorshub.com/boards/board_surveymenu.asp?board_id=1418
and select survey #88.

All votes are anonymous. You may also vote in any other survey in which you have not already voted.